IllExcor Therapeutics LLC
Illexcor-Home
Richmond, United States · Founded 2020
- Headquarters
- Richmond, Virginia
- Employees
- 1–10
- Founded
- 2020
- Business Model
- B2B
- Website
- illexcor.com
- Last Round
- GrantMar 2025
- Rounds
- 2
About
IllExcor Therapeutics is a pre-clinical stage biopharmaceutical company focused on small molecule drug discovery for sickle cell disease and related conditions. Their lead compound ILX002 targets sickle cell disease through a novel prodrug approach, supported by NIH SBIR Phase I funding. The company is developing an oral drug pipeline for blood disorders.
Summary
IllExcor Therapeutics LLC is a Biotech company based in Richmond, United States, founded in 2020. Its most recent funding was a Grant round in Mar 2025. Investors include Department of Health and Human Services.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Mar 2025
Sign up to see all 2 rounds
Grant through Venture Round — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/illexcor-therapeutics-llc"><img src="https://indexed.vc/api/badge/company/illexcor-therapeutics-llc" alt="IllExcor Therapeutics LLC on Indexed.vc" width="260" height="76" /></a>